Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Understanding and Relieving of Neuropathic Disorders in the Long COVID

Author(s): Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros and Jean-Marc Sabatier*

Volume 23, Issue 4, 2023

Published on: 08 March, 2023

Article ID: e270223214061 Pages: 3

DOI: 10.2174/1871526523666230227113205

Open Access Journals Promotions 2
[1]
Michael-Titus A, Shortland P, Hughes SH. The Nervous System. (3rd ed.), Elsevier 2023.
[2]
Earley YF, Souza LAC. (Pro)renin receptor and blood pressure regulation: A focus on the central nervous system. Curr Hypertens Rev 2022; 18(2): 101-16.
[http://dx.doi.org/10.2174/1570162X20666220127105655] [PMID: 35086455]
[3]
Cabandugama PK, Gardner MJ, Sowers JR. The renin angiotensin aldosterone system in obesity and hypertension. Med Clin North Am 2017; 101(1): 129-37.
[http://dx.doi.org/10.1016/j.mcna.2016.08.009] [PMID: 27884224]
[4]
Pontes RB, Girardi ACC, Nishi EE, Campos RR, Bergamaschi CT. Crosstalk between the renal sympathetic nerve and intrarenal angiotensin II modulates proximal tubular sodium reabsorption. Exp Physiol 2015; 100(5): 502-6.
[http://dx.doi.org/10.1113/EP085075] [PMID: 25858030]
[5]
Fajloun Z, Kovacic H, Annweiler C, Wu Y, Cao Z, Sabatier JM. SARS-CoV-2-induced neurological disorders in symptomatic COVID-19 and long COVID patients: Key role of brain renin-angiotensin system. Infect Disord Drug Targets 2022; 22(5): e060422203203.
[http://dx.doi.org/10.2174/1871526522666220406124618] [PMID: 35388764]
[6]
El-Arif G, Farhat A, Khazaal S, et al. The renin-angiotensin system: A key role in SARS-CoV-2-induced COVID-19. Molecules 2021; 26(22): 6945.
[http://dx.doi.org/10.3390/molecules26226945] [PMID: 34834033]
[7]
El-Arif G, Khazaal S, Farhat A, et al. Angiotensin II type I receptor (AT1R): The gate towards COVID-19-associated diseases. Molecules 2022; 27(7): 2048.
[http://dx.doi.org/10.3390/molecules27072048] [PMID: 35408447]
[8]
Khazaal S, Harb J, Rima M, et al. The pathophysiology of long COVID throughout the renin-angiotensin system. Molecules 2022; 27(9): 2903.
[http://dx.doi.org/10.3390/molecules27092903] [PMID: 35566253]
[9]
Annweiler C, Cao Z, Papon N, Kovacic H, Sabatier JM. Counter-regulatory renin-angiotensin system: An important line of research to understand and limit the severity of COVID-19. Infect Disord Drug Targets 2022; 22(2): e100921196331.
[http://dx.doi.org/10.2174/1871526521666210910063227] [PMID: 34515015]
[10]
Harb J, Debs N, Rima M, et al. SARS-CoV-2, COVID-19, and reproduction: Effects on fertility, pregnancy, and neonatal life. Biomedicines 2022; 10(8): 1775.
[http://dx.doi.org/10.3390/biomedicines10081775] [PMID: 35892675]
[11]
LeBouef T, Yaker Z, Whited L. Physiology, autonomic nervous system.In: StatPearls. Treasure Island, FL: StatPearls Publishing 2022.
[12]
Juster-Switlyk K, Smith AG. Updates in diabetic peripheral neuropathy. F1000 Res 2016; 5: 1-7.
[http://dx.doi.org/10.12688/f1000research.7898.1]
[13]
Henriksen EJ, Prasannarong M. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle. Mol Cell Endocrinol 2013; 378(1-2): 15-22.
[http://dx.doi.org/10.1016/j.mce.2012.04.011] [PMID: 22564510]
[14]
Henriksen EJ, Jacob S. Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition. J Cell Physiol 2003; 196(1): 171-9.
[http://dx.doi.org/10.1002/jcp.10294] [PMID: 12767053]
[15]
Fajloun Z, Abi Khattar Z, Kovacic H, Legros C, Sabatier JM. SIBO: The trail of a "new" human pathology associated with multiple severe and disabling COVID-19 and long COVID symptoms or induced by the anti-COVID-19 vaccine. Infect Disrod Drug Targets 2023. Epub ahead of print.
[http://dx.doi.org/10.2174/1871526523666230210162334] [PMID: 36762752]
[16]
Brito-Zerón P, Acar-Denizli N, Romão VC, et al. Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection. Clin Exp Rheumatol 2021; 39(Suppl 133 6): 57-65.
[http://dx.doi.org/10.55563/clinexprheumatol/0anatx]
[17]
Annweiler C, Cao Z, Wu Y, et al. Counter-regulatory ‘Renin-angiotensin’ system-based candidate drugs to treat COVID-19 diseases in SARS-CoV-2-infected patients. Infect Disord Drug Targets 2020; 20(4): 407-8.
[http://dx.doi.org/10.2174/22123989MTA2cNzIlw] [PMID: 32418532]
[18]
Mehraeen E, Najafi Z, Hayati B, et al. Current treatments and therapeutic options for COVID-19 patients: A systematic review. Infect Disord Drug Targets 2022; 22(1): e260721194968.
[http://dx.doi.org/10.2174/1871526521666210726150435] [PMID: 34313204]
[19]
Balogun TA, Chukwudozie OS, Ogbodo UC, et al. Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling. Front Chem 2022; 10: 964446.
[http://dx.doi.org/10.3389/fchem.2022.964446] [PMID: 36304744]
[20]
Annweiler C, Papon N, Sabatier JM, Barré J. DAMPening severe COVID-19 with dexamethasone. Infect Disord Drug Targets 2022; 22(2): e270821195910.
[http://dx.doi.org/10.2174/1871526521999210827142839] [PMID: 34455971]
[21]
Annweiler C, Hanotte B, Grandin de l’Eprevier C, Sabatier JM, Lafaie L, Célarier T. Vitamin D and survival in COVID-19 patients: A quasi-experimental study. J Steroid Biochem Mol Biol 2020; 204: 105771.
[http://dx.doi.org/10.1016/j.jsbmb.2020.105771] [PMID: 33065275]
[22]
Cao Z, Wu Y, Faucon E, Sabatier JM. SARS-CoV-2 & COVID-19: Key-roles of the ‘Renin-Angiotensin’ system / Vitamin D impacting drug and vaccine developments. Infect Disord Drug Targets 2020; 20(3): 348-9.
[http://dx.doi.org/10.2174/22123989MTA2nMzg9x] [PMID: 32370727]

Rights & Permissions Print Cite
Article Metrics
17
4
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy